Glutamine decreases lipopolysaccharide-induced intestinal inflammation in infant rats

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 286, Issue 6 49-6, 2004, Pages

  Li, Nan ^a   Liboni, Kellym ^a   Fang, Mao Zhong ^a   Samuelson, Don ^a   Lewis, Patricia ^a   Patel, Roshan ^a   Neu, Josef ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Nutrition; Proinflammatory response

Indexed keywords

CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; GLUTAMIC ACID; GLUTAMINE; INTESTINE ENZYME; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; ALPHA CHEMOKINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT, RAT; CYTOKINE-INDUCED NEUTROPHIL CHEMOATTRACTANT, RAT; PEPTIDE FRAGMENT; PEROXIDASE; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY GROWTH; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENTERITIS; ENZYME ACTIVITY; GASTROSTOMY; INTESTINE VILLUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; PROTEIN MALNUTRITION; RAT; SMALL INTESTINE; ANIMAL; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; INTESTINE; METABOLISM; NEWBORN; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; CHEMOKINES, CXC; DIETARY PROTEINS; ENTERITIS; GLUTAMINE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTESTINES; LIPOPOLYSACCHARIDES; PEPTIDE FRAGMENTS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2642555461     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00493.2003     Document Type: Article

References (55)

1. Abcouwer SF and Souba WW. Is glutamine a pretender to the throne? Nutrition 15: 71-72, 1999.
2. Aosasa S, Mochizuki H, Yamamoto T, Ono S, and Ichikura T. A clinical study of the effectiveness of oral glutamine supplementation during total parenteral nutrition: influence on mesenteric mononuclear cells. JPEN J Parenter Enteral Nutr 23, Suppl 5: S41-S44, 1999.
3. Auestad N, Korsak RA, Bergstrom JD, and Edmond J. Milk-substitutes comparable to rat's milk; their preparation, composition, and impact on development and metabolism in the artificially reared rat. Br J Nutr 61: 495-518, 1989.
4. Battaglia F and Regnault T. Placental transport and metabolism of amino acids. Placenta: 145-161, 2001.
5. Beaulieu JF and Calvert R. Permissive effect of glutamine on the differentiation of fetal mouse small intestine in organ culture. Differentiation 29: 50-55, 1985.
6. Burrin DG, Stoll B, Jiang R, Chang X, Hartmann B, Holst JJ, Greeley GHJ, and Reeds PJ. Minimal enteral nutrient requirements for intestinal growth in neonatal piglets: how much is enough? Am J Clin Nutr 71: 1603-1610, 2000.
7. Cerra FB, Siegel JH, Coleman B, Border JR, and McMenamy RR. Septic autocannabalism. Ann Surg 192: 570-580, 1980.
8. Coeffier M, Marion R, Leplingard A, Lerebours E, Ducrotte P, and Dechelotte P. Glutamine decreased interleukin-8 and interleukin-6 but not nitric oxide and prostaglandins E2 production by human gut in-vitro. Cytokine 18: 92-97, 2002.
9. Coeffier M, Miralles-Barrachina O, Le Pessot F, Lalaude O, Daveau M, Lavoinne A, Lerebours E, and Dechelotte P. Influence of glutamine on cytokine production by human gut in vitro. Cytokine 13: 148-154, 2001.
10. Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, and Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 38: 216-222, 1996.
11. De Bont ES, Martens A, van Raan J, Samson G, Fetter WP, Okken A, de Leij LH, and Kimpen JL. Diagnostic value of plasma levels of tumor necrosis factor a (TNFα) and interleukin-6 (IL-6) in newborns with sepsis. Acta Paediatr Jpn 83: 696-699, 1994.
12. Dudley DJ. Pre-term labor: an intra-uterine inflammatory response syndrome. J Reprod Immunol 36: 93-109, 1997.
13. Ertel W, Scholl FA, Gallati H, Bonaccio M, Schildberg FW, and Trentz O. Increased release of soluble tumor necrosis factor receptors into blood during clinical sepsis. Arch Surg 129: 1330-1337, 1994.
14. Fong YM, Marano MA, Moldawer LL, Wei H, Calvano SE, Kenney JS, and Allison AC. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 85: 1896-1904, 1990.
15. Fox AD, Kripke SA, De-Paula J, Berman JM, Settle RG, and Rombeau JL. Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. JPEN J Parenter Enteral Nutr 12: 325-31, 1988.
16. Griffiths RD, Jones C, and Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 13: 295-302, 1997.
17. Hall WG. Weaning and growth of artificially-reared rats. Science 190: 1313-1315, 1975.
18. Harada K, Toyonaga A, Mitsuyama K, Sasaki E, and Tanikawa K. Role of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in rat experimental colitis. Digestion 55: 179-180, 1995.
19. Henning SJ. Biochemistry of intestinal development. Environ Health Perspect 33: 9-16, 1979.
20. Henning SJ. Ontogeny of enzymes in the small intestine. Annu Rev Physiol 47: 231-45, 1985.
21. Henning SJ. Postnatal development: coordination of feeding, digestion, and metabolism. Am J Physiol Gastrointest Liver Physiol 241: G199-G214, 1981.
22. Henning SJ. Postnatal development of jejunal sucrase: independence from cyclic AMP. Biol Neonate 37: 246-253, 1980.
23. Houdijk AP, Rijnsburger ER, Jansen J, Wesdorp RI, Weiss JK, McCamish MA, Teerlink T, Meuwissen SG, Haarman HJ, Thijs LG, and van Leeuwen PA. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 352: 772-776, 1998.
24. Hsieh CS, Huang CC, Wu JJ, Chaung HC, Wu CL, Chang NK, Chang YM, Chou MH, and Chuang JH. Ascending cholangitis provokes IL-8 and MCP-1 expression and promotes inflammatory cell infiltration in the cholestatic rat liver. J Pediatr Surg 36: 1623-1628, 2001.
25. Huang Y, Li N, Liboni K, and Neu J. Glutamine decreases lipopolysaccharide-induced IL-8 production in Caco-2 cells through a non-NF-κB p50 mechanism. Cytokine 22: 77-83, 2003.
26. Ishii H, Ishibashi M, Takayama M, Nishida T, and Yoshida M. The role of cytokine-induced neutrophil chemoattractant-1 in neutrophil-mediated remote lung injury after intestinal ischaemia/reperfusion in rats. Respirology 5: 325-331, 2000.
27. Kudsk KA. Current aspects of mucosal immunology and its influence by nutrition. Am J Surg 183: 390-398, 2002.
28. Lacey J, Crouch S, and Benfell K. Glutamine supplemented parenteral nutrition is associated with improved outcome in preterm infants. JPEN J Parenter Enteral Nutr 20: 74-80, 1996.
29. Lin MT, Saito H, Fukushima R, Inaba T, Fukats K, Inoue T, Furukawa S, Han I, and Muto T. Route of nutritional supply influences local, systemic, and remote organ responses to intraperitoneal bacterial challenge. Ann Surg 223: 84-93, 1996.
30. MacBurney M, Young LS, Ziegler TR, and Wilmore DW. A cost-evaluation of glutamine-supplemented parenteral nutrition in adult bone marrow transplant patients. J Am Diet Assoc 94: 1263-1266, 1994.
31. Mainous MR, Ertel W, Chaudry IH, and Deitch EA. The gut: a cytokine-generating organ in systemic inflammation? Shock 4: 193-199, 1995.
32. Morecroft JA, Spitz L, Hamilton PA, and Holmes SJK. Necrotizing enterocolitis-multisystem organ failure of the newborn? Acta Paedr 394: 21-23, 1994.
33. Nelson KB, Dambrosia JM, Grether JK, and Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 44: 665-675, 1998.
34. Neu J, Auestad N, and DeMarco VG. Glutamine metabolism in the fetus and critically ill low birth weight neonate. Adv Pediatr 49, 2002.
35. Neu J, Roig JC, Meetze WH, Veerman M, Carter C, Millsaps M, Bowling D, Dallas MJ, Sleasman J, Knight T, and Auestad N. Enteral glutamine supplementation for very low birth weight infants decreases morbidity. J Pediatr 131: 691-699, 1997.
36. Novak F, Heyland DK, Avenell A, Drover JW, and Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 30: 2002-2009, 2002.
37. Panigrahi P, Gewolb IH, Bamford P, and Horvath K. Role of glutamine in bacterial transcytosis and epithelial cell injury. JPEN J Parenter Enteral Nutr 21: 75-80, 1997.
38. Porter EM, Bevins CL, Ghosh D, and Ganz T. The multifaceted Paneth cell. Cell Mol Life Sci 59: 156-70, 2002.
39. Potsic B, Holliday N, Lewis P, Samuelson D, DeMarco V, and Neu J. Glutamine supplementation and deprivation: effect on artificially reared rat small intestinal morphology. Pediatr Res 52: 430-436, 2002.
40. Qu XD, Lloyd KC, Walsh JH, and Lehrer RI. Secretion of type II phospholipase A2 and cryptdin by rat small intestinal Paneth cells. Infect Immun 64: 5161-5165, 1996.
41. Rhoads JM. Glutamine signaling in intestinal cells. J Parent Enteral Nutr 23, Suppl 5: S38-S40, 1999.
42. Rhoads JM, Argenzio RA, Chen W, Rippe RA, Westwick JK, Cox AD, Berschneider HM, and Brenner DA. 1-Glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. Am J Physiol Gastrointest Liver Physiol 272: G942-G953, 1997.
43. Sansonetti PJ, Arondel J, Huerre M, Harada A, and Matsushima K. Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis. Infect Immun 67: 1471-1480, 1999.
44. Sarcia PJ, Scumpia PO, Moldawer LL, DeMarco VG, and Skimming JW. Hypothermia induces interleukin-10 and attenuates injury in the lungs of endotoxemic rats. Shock 20: 41-45, 2003.
45. Souba WW. Glutamine Physiology, Biochemistry, and Nutrition in Critical Illness. Austin, TX: Landes, 1992.
46. Souba WW, Klimberg VS, Plumley DA, Salloum RM, Flynn TC, Bland KI, and Copeland EM 3rd. The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection. J Surg Res 48: 383-391, 1990.
47. Stappenbeck TS, Hooper LV, and Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 99: 15451-15455, 2002.
48. Van der Poll T, JJ, van Leenen D, von der Mohlen M, Levi M, ten Cate H, Gallati H, ten Cate JW, and van Deventer SJ. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J Infect Dis 168: 955-960, 1993.
49. Vaughn P, Thomas P, Clark R, and Neu J. Enteral glutamine supplementation and morbidity in low birthweight infants. J Pediatr 142: 662-668, 2003.
50. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50: 553-562, 2001.
51. Weiss MD, DeMarco V, Strauss DM, Samuelson DA, Lane ME, and Neu J. Glutamine synthetase: a key enzyme for intestinal epithelial differentiation? JPEN J Parenter Enteral Nutr 23: 140-146, 1999.
52. Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM, and Chang EB. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 16: 393-402, 2001.
53. Wischmeyer PE, Lynch J, Liedel J, Wolfson R, Riehm J, Gottlieb L, and Kahana M. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med 29: 2075-2080, 2001.
54. Yamasaki Y, Itoyama Y, and Kogure K. Involvement of cytokine production in pathogenesis of transient cerebral ischemic damage. Keio J Med 45: 225-229, 1996.
55. Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R, Morrow FD, Jacobs DO, Smith RJ, and Antin JH. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 116: 821-828, 1992.